The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey

BackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nancy Samir Elbarbary, Tiago Jeronimo dos Santos, Carine de Beaufort, Esko Wiltshire, Aman Pulungan, Andrea Enzo Scaramuzza
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/4bd21a4b7fea49ee9a057326af2f0232
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4bd21a4b7fea49ee9a057326af2f0232
record_format dspace
spelling oai:doaj.org-article:4bd21a4b7fea49ee9a057326af2f02322021-11-05T12:18:32ZThe Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey1664-239210.3389/fendo.2021.735554https://doaj.org/article/4bd21a4b7fea49ee9a057326af2f02322021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fendo.2021.735554/fullhttps://doaj.org/toc/1664-2392BackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles, clinic sizes, their country of practice, and the impact of COVID-19 on endocrine diseases were investigated.ResultsRespondents from 131 pediatric endocrine centers in 51 countries across all continents completed the survey. Routine check-ups and education were altered in most pediatric endocrine clinics. Over 20% of clinics experienced a shortage of critical medications or essential supplies. ICU treatment was required for patients with diabetes and COVID-19 in 21.2% of centers. In diabetes, 44% of respondents reported increased diabetic ketoacidosis episodes in newly diagnosed cases and 30% in established cases. Biopsychosocial and behavioral changes were explicitly reported to be occurring among pediatric patients with endocrine disorders.ConclusionsThis large global survey conducted during the COVID-19 pandemic highlights that diabetes is more challenging to manage than any other pediatric endocrine disorder, with an increased risk of morbidity. Psychological distress due to COVID-19 needs to be recognized and addressed. The importance of close contact with healthcare professionals should be emphasized, and medical supplies should be readily available to all patients.Nancy Samir ElbarbaryTiago Jeronimo dos SantosTiago Jeronimo dos SantosCarine de BeaufortCarine de BeaufortEsko WiltshireEsko WiltshireAman PulunganAndrea Enzo ScaramuzzaFrontiers Media S.A.articleCOVID-19childrendiabetesobesity and metabolic syndromeadrenalthyroidDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENFrontiers in Endocrinology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
children
diabetes
obesity and metabolic syndrome
adrenal
thyroid
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle COVID-19
children
diabetes
obesity and metabolic syndrome
adrenal
thyroid
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
description BackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles, clinic sizes, their country of practice, and the impact of COVID-19 on endocrine diseases were investigated.ResultsRespondents from 131 pediatric endocrine centers in 51 countries across all continents completed the survey. Routine check-ups and education were altered in most pediatric endocrine clinics. Over 20% of clinics experienced a shortage of critical medications or essential supplies. ICU treatment was required for patients with diabetes and COVID-19 in 21.2% of centers. In diabetes, 44% of respondents reported increased diabetic ketoacidosis episodes in newly diagnosed cases and 30% in established cases. Biopsychosocial and behavioral changes were explicitly reported to be occurring among pediatric patients with endocrine disorders.ConclusionsThis large global survey conducted during the COVID-19 pandemic highlights that diabetes is more challenging to manage than any other pediatric endocrine disorder, with an increased risk of morbidity. Psychological distress due to COVID-19 needs to be recognized and addressed. The importance of close contact with healthcare professionals should be emphasized, and medical supplies should be readily available to all patients.
format article
author Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
author_facet Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
author_sort Nancy Samir Elbarbary
title The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_short The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_full The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_fullStr The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_full_unstemmed The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_sort challenges of managing pediatric diabetes and other endocrine disorders during the covid-19 pandemic: results from an international cross-sectional electronic survey
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/4bd21a4b7fea49ee9a057326af2f0232
work_keys_str_mv AT nancysamirelbarbary thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT amanpulungan thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT andreaenzoscaramuzza thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT nancysamirelbarbary challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT amanpulungan challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT andreaenzoscaramuzza challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
_version_ 1718444286614175744